There are a lot of startups looking at your DNA these days but uBiome stands out as unique among them for testing the DNA of microorganisms found in your fecal matter.
These bugs have a lot to do with your health and the startup is launching a clinical screening test called SmartGut to sequence the DNA of those microbes.
uBiome tells TechCrunch it has also closed on $22 million in Series B… Read More
from TechCrunch